M Tomonaga

Prognostic significance of the morphological dysplastic changes in chronic myelogenous leukemia.

M. Tomonaga, Y. Yoshida, I. Jinnai, 1986, Leukemia research.

Biosynthetic (recombinant) human granulocyte-macrophage colony-stimulating factor: effect on normal bone marrow and leukemia cell lines.

M. Tomonaga, D. Golde, J. Gasson, 1986, Blood.

A randomized trial comparing interferon-alpha with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phase.

R Ohno, H. Dohy, N. Kamada, 1995, Blood.

The percentage of myeloperoxidase-positive blast cells is a strong independent prognostic factor in acute myeloid leukemia, even in the patients with normal karyotype

R Ohno, T Kobayashi, M. Tomonaga, 2003, Leukemia.